Genomic changes of Klebsiella pneumoniae and Enterobacter cloacae in ICU patients over time
Official title: Epidemiology and Overtime Genomic Evolution of Klebsiella Pneumoniae and Enterobacter Cloacae Complex (ECC) in Stools of ICU's Patients
Run by University Hospital, Caen · NCT07744321 · Data updated 2026-11-12
This study tests how the gut bacteria Klebsiella pneumoniae and Enterobacter cloacae evolve over time in adults in ICUs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital, Caen Academic / other |
| Locations | 1 site (Caen) |
| Status | Recruiting |
| Started | January 20, 2023 |
| Main results expected | January 20, 2027 |
| Study ends | January 20, 2028 |
| Registry record updated | August 4, 2026 |
| Trial ID | NCT07744321 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older admitted to medical or surgical ICUs with planned stay of 28 days or more and at least four rectal swabs, who speak French and are insured, without recent hospitalization.
✕Probably not a fit
Patients who do not meet the sampling requirements or who have an early discharge may not benefit from study findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows adults admitted to medical or surgical ICUs for at least 28 days, collecting rectal swabs to track the genomic changes of Klebsiella pneumoniae and Enterobacter cloacae over time. It aims to understand how these bacteria persist or evolve in the ICU environment and their potential links to infections. No interventions are given; the study analyzes samples to map longitudinal genomic stability and diversification. Eligible participants must be French-speaking adults with extended ICU stays and multiple swabs, with several inclusion and exclusion criteria to ensure reliable data. Results could inform infection control and future research on MDR organisms in critical care settings.
Why it matters
Potential benefit: If successful, findings could improve understanding of how these bacteria evolve in the ICU and inform strategies to prevent infections and transmission.
How similar studies have gone: Previous work has highlighted the importance of genomic characterization of Klebsiella and Enterobacter species in hospital settings, supporting the value of longitudinal genomic studies in ICUs.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥18 years old. * Hospitalization in medical and / or surgical ICU of a duration greater than or equal to 28 days and the production of 4 rectal swabs. * Absence of hospitalization in the last 4 months before inclusion * French speaking patient * Patient affiliated to the social security system * Patient having received an informed opinion on the study and collection of the non-opposition to the latter * Person of trust or family member who has received an informed opinion on the study and the collection of non-opposition to the latter when the patient is judged as incapable of expressing his non-opposition. Exclusion Criteria: * Pregnant or lactating woman * Hospitalization within 4 months before inclusion * Patient whose hospital stay is \<28 days or rectal swabs less than 4 * Absence of Kpn or ECC in the first rectal sample taken * Patient under guardianship / curatorship * Patient deprived of liberty * Patient under judicial protection * Patient not affiliated to the social security system * Refusal to participate in the study requested by the patient or the designated confidential counselor or a designated family member.
Where it's running
-
Caen University Hospital
Caen, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using blood cell ratios and procalcitonin to predict outcomes for adults with sepsis in the ICU
This project will test whether routine blood measures—neutrophil-to-lymphocyte-and-platelet ratio, procalcitonin, and total white blood cell count—can help predict outcomes for adults with sepsis in the intensive care unit.
-
Two eye care methods to prevent eye problems in ventilated ICU patients
This tests whether using an eye care kit, a written eye-care protocol, or both will reduce eye complications compared with standard care in adults on mechanical ventilation in the ICU.
-
Virtual reality to improve comfort for adults in the surgical ICU
This trial will try immersive virtual reality (HypnoVR) sessions to reduce discomfort for adults who stay at least 48 hours in the surgical intensive care unit after major cardiothoracic or abdominal surgery.
-
Calibration of esophageal balloon catheter for patients on mechanical ventilation
This study is testing how to better calibrate a special balloon used in the esophagus to measure pressure in patients on mechanical ventilation, to see if it helps improve their care.
-
Improving care for critically ill children in Asia
This study is trying to improve care for critically ill children in Asian hospitals by collecting data to find out what helps or harms their recovery and using that information to create tools that predict their outcomes.
-
Predicting blockages in external ventricular drains for ICU patients
This study is trying to find out which ICU patients with external ventricular drains are at higher risk for blockages after bleeding in the brain, to help improve their care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.